CDKN2A and skin squamous cell carcinoma: Cyclins, cyclin-dependent kinases, and their inhibitors, such as p16INK4a, are altered in cSCC, resulting in uncontrolled cell cycle progression and increased proliferation (Juliano, 2020[93]).